论文信息 - Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension - 字舞流文

Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension

S. Vermeire | R. Panaccione | S. Danese | M. Abreu | M. Chiorean | A. Afzali | M. Osterman | A. Dignass | J. Colombel | G. Lawlor | Anjali Jain | M. Regueiro | Subrata Ghosh | J. Canavan | A. Petersen | L. Charles | D. Rubin | D. Wolf | Hsiuanlin Wu